News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
Browse EHA2024 content on demand on the Congress Platform – European Hematology Association
Photo taken from European Hematology Association/X
Jun 29, 2024, 04:01

Browse EHA2024 content on demand on the Congress Platform – European Hematology Association

European Hematology Association posted on X:

“Did you miss a session in Madrid? Make sure to browse content from EHA2024, now available on demand on the Congress Platform until August 15.

Not registered? You can still register for online access until June 30.”

Source: European Hematology Association/X
.

August 15 cancer Congress Platform EHA2024 European Hematology Association Hematology Madrid Medical Conference OncoDaily Oncology online access registration Virtual Event
Insight
Jul 1, 2024, 07:31
Dan Vahdat: Digital-first cancer care for all
Blog
Jul 1, 2024, 06:50
Am I Doing Enough? - Pat Garcia-Gonzalez
Insight
Jul 1, 2024, 06:22
Partnership with Novartis for over 20 years - The Max Foundation
Insight
Jul 1, 2024, 06:11
Conquer Cancer has awarded more than $11 million to physician-scientists at the ASCO Annual Meeting
Drugs
Jul 1, 2024, 06:09
FDA has approved EPKINLY for the treatment of adults with relapsed/refractory follicular lymphoma - Genmab
Insight
Jul 1, 2024, 05:52
The final showcase event of PROTECT-EUROPE and SmartCARE - ECO
Cancer Types
Jul 1, 2024, 05:46
Endometrioid Adenocarcinoma: What patients should know about
Insight
Jul 1, 2024, 05:32
Douglas Flora: AI for mental health and patient support
Blog
Jul 1, 2024, 03:19
Shahrin Ahmed: MED12 is identified as being instrumental in basal-like pancreatic cancer
Blog
Jul 1, 2024, 03:08
Stephen V Liu: Phase III Adjuvant BR.31 study does not meet primary endpoint
Blog
Jul 1, 2024, 02:54
Erman Akkus: Take home messages from Proffered Papers session at ESMOGI24
Blog
Jul 1, 2024, 02:31
Biagio Ricciuti receives a 2024 IASLC YIA to develop new therapies for KRAS amplified NSCLC